A widely available commercial weight-management program led to greater reductions in weight than an unstructured, do-it-yourself (DIY) approach, according to new data published recently in JAMA ...
CVS Health shared data from its CVS Weight Management program in which participants achieved more than 15% weight loss on average, including existing anti-obesity medication users who succeeded in ...
Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep ...
WW International, Inc. ((WW)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
CVS Health CVS recently released compelling data from its CVS Weight Management program, with participants achieving more than 15% weight loss, on average. This includes existing anti-obesity ...
WW International Inc. (NASDAQ:WW) said its Med+ members will gain access to reduced pricing for Wegovy through an expanded ...
To achieve greater weight loss, WW International (WW) -- more commonly known as Weight Watchers—found that engaging in Weight Watchers' GLP-1 Success Program along with weight loss medications ...
A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...
Investments in pharmacy benefits infrastructure, in-home lab services and new treatment options expand platform capabilities and are estimated to increase LifeMD’s addressable weight loss market by 15 ...
LOS ANGELES, Oct. 20, 2025 /PRNewswire/ -- L-Nutra, the global leader in longevity and nutrition science, has been named a Top Vendor by Shortlister for Q4 2025 in both Corporate Weight Management and ...
The Center for Healthy Living (CHL) is launched a new, free weight management program in 2025. This free program is designed to provide benefits-eligible employees and covered dependents with an ...
The announcement comes as GLP-1 receptor agonist medications, a class of FDA-approved therapies used to treat obesity by ...